期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Acyl-coenzyme A: cholesterol acyltransferase family
1
作者 Yali LIU Zhanyun GUO 《Frontiers in Biology》 CSCD 2009年第2期129-136,共8页
The enzymes of the acyl-coenzyme A:cholesterol acyltransferase(ACAT)family are responsible for the in vivo synthesis of neutral lipids.They are potential drug targets for the intervention of atherosclerosis,hyperlipid... The enzymes of the acyl-coenzyme A:cholesterol acyltransferase(ACAT)family are responsible for the in vivo synthesis of neutral lipids.They are potential drug targets for the intervention of atherosclerosis,hyperlipidemia,obesity,type II diabetes and even Alzheimer’s disease.ACAT family enzymes are integral endoplasmic reticulum(ER)membrane proteins and can be divided into ACAT branch and acyl-coenzyme A:diacylglycerol acyltransferase 1(DGAT1)branch according to their substrate specificity.The ACAT branch catalyzes synthesis of cholesteryl esters using long-chain fatty acyl-coenzyme A and cholesterol as substrates,while the DGAT1 branch catalyzes synthesis of triacylglycerols using fatty acylcoenzyme A and diacylglycerol as substrates.In this review,we mainly focus on the recent progress in the structural research of ACAT family enzymes,including their disulfide linkage,membrane topology,subunit interaction and catalysis mechanism. 展开更多
关键词 LIPID acyl-coenzyme A:cholesterol acyltransferase(ACAT) acyl-coenzyme A:diacylglycerol acyltransferase 1(DGAT1) acyltransferase CATALYSIS
原文传递
Effect of Astragalus Angelica Mixture(黄芪当归合剂)on Lipoprotein Lipase and Lecithin Cholesterol Acyltransferase of Nephrotic Rats
2
作者 李宁军 李惊子 +3 位作者 辛岗 许远 洪健美 王海燕 《Chinese Journal of Integrative Medicine》 SCIE CAS 1999年第4期287-287,共1页
关键词 Effect of Astragalus Angelica Mixture on Lipoprotein Lipase and Lecithin cholesterol acyltransferase of Nephrotic Rats
原文传递
Conjugated Linoleic Acid and Dietary Fats Differentially Affect Hepatic ACAT Activity and LDL-Cholesterol in Postweanling Pigs Fed Low-Fat Diets
3
作者 S.B.Smith T.A.Wilson +2 位作者 C.D.Gilbert D.R.Smith H.J.Mersmann 《Journal of Animal Science and Biotechnology》 SCIE CAS 2010年第2期75-84,共10页
ABSTRACT:Two separate studies tested the hypoth- esis that plasma low-density lipoprotein cholesterol LDL-C ) can be decreased by conjugated linoleic acid (CLA) by depressing hepatic acyl-coenzyme A: cholesterol... ABSTRACT:Two separate studies tested the hypoth- esis that plasma low-density lipoprotein cholesterol LDL-C ) can be decreased by conjugated linoleic acid (CLA) by depressing hepatic acyl-coenzyme A: cholesterol acyltransferase (ACAT) activity. In the first experiment, 3 groups of 6 early-weaned piglets were fed low-fat diets containing either 1.5% CLA, 1.5% corn oil or 1.5% beef tallow;fat provided 8% of the energy intake. In the second experiment, 4 groups of 6 early-weaned piglets were fed high-fat di- ets containing either 15% beef tallow, 12% beef tal- low plus 3% CLA, 15% corn oil, or 12% corn oil plus 3% CLA; fat provided 29% of energy intake. Cholesterol was balanced across diets in both experi-ments. In pigs fed the low-fat diets, all dietary fats in- creased LDL-C and triacylglycerols and decreased high-density lipoprotein cholesterol ( HDL-C ) and very low-density lipoprotein cholesterol (VLDL-C). LDL-C was the same in pigs fed low-fat tallow or low-fat CLA diets. However, ACAT activity was near- ly 80% higher in pigs fed the low-fat tallow diet than in pigs fed the low-fat CLA diets. All high-fat diets increased LDL-C, HDL-C and triacylglycerols equally with no effect on VLDL-C. There were no unique fat- ty acid effects of the high-fat diets on ACAT activity. We conclude that supplemental fats had differential effects on hepatic ACAT activity and LDL-C, but on- ly in pigs fed low-fat diets. 展开更多
关键词 acyl-coenzyme A: cholesterol acyltransferase conjugated linoleic acid fatty acids liver PIGS
下载PDF
Alzheimer’s disease:Risk factors and therapeutic targets
4
作者 Laxman Pokhrel 《Journal of Coastal Life Medicine》 2015年第9期752-755,共4页
Alzheimer’s disease(AD),a neurodegenerative disorder,has been determined as an outcome of genetic as well as behavioral conditions.The complete understanding of its generation and progress is yet to be understood.How... Alzheimer’s disease(AD),a neurodegenerative disorder,has been determined as an outcome of genetic as well as behavioral conditions.The complete understanding of its generation and progress is yet to be understood.However,there has been a significant progress in the diagnosis and identification of the associated risk factors of AD.Several of the risk factors were found connected with cholesterol.Scientists are mainly focusing on the reduction of amyloid β and stabilization of tau protein towards the development of its drugs.To modulate amyloid β,the key components of cholesterol metabolism have been attractive targets and the enzymes involved in the phosphorylation of tau have been tried to stabilize tau protein.This review article briefly highlights the symptoms,risk factors,and drug targets of AD. 展开更多
关键词 Amyloidβ Amyloid precursor protein Acyl coenzymeA:cholesterol acyltransferase Liver X receptor 27-Hydroxycholesterol Tau protein
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部